Data-Gap Analysis

Data-Gap-Analysis-Toxicological-Assessment

  • Identify key toxicity studies required for regulatory compliance and safety assessment

  • Evaluate the existing data and identify any gaps or missing studies

  • Determine the need for additional studies to fill the data gaps or ensure regulatory compliance

  • Conduct literature reviews to identify any existing data or studies to address the data gaps

    • Assess the quality and relevance of available data to meet regulatory requirements

  • Provide recommendations for filling the data gaps, including study design and implementation

    • Develop a comprehensive plan for conducting the necessary studies

    • Collaborate with CROs or analytical labs to execute the studies

    • Assist in the coordination and management of the data collection process

  • Analyze the collected data and provide a comprehensive report on the findings

  • Ensure compliance with regulatory guidelines and requirements

  • Offer ongoing support and guidance throughout the data gap analysis process

Frequently Asked Questions

  • Data Gap Analysis is a systematic review that pinpoints missing toxicology, safety, or compliance data essential for regulatory approval. It ensures that every requirement—whether scientific or regulatory—is mapped, measured, and addressed.

  • Early identification prevents duplicate testing, late-stage regulator requests, or submission rejections. Strong Data Gap Analysis accelerates approvals, reduces unnecessary studies, and protects business timelines, resources, and reputation.

  • SciQra follows a structured, regulatory-aligned process. We identify key toxicity studies needed for compliance and safety, assess existing dossiers, literature, and study data for quality and relevance, highlight deficiencies with precision and recommend strategic solutions

  • No. It is indispensable across industries including cosmetics, consumer products, medical devices, dietary supplements, and industrial chemicals. The regulatory expectations differ, but the principle is universal: close the gaps early, or risk compliance delays, financial losses, and regulatory setbacks.

  • SciQra goes beyond identification. We provide a clear action roadmap—scientifically sound study designs, CRO and lab coordination, literature-bridging strategies, and compliance-ready documentation. Our approach transforms gaps into opportunities for faster approvals and stronger regulatory confidence.